NO981388L - Bedring av Dupuytrens sykdom - Google Patents

Bedring av Dupuytrens sykdom

Info

Publication number
NO981388L
NO981388L NO981388A NO981388A NO981388L NO 981388 L NO981388 L NO 981388L NO 981388 A NO981388 A NO 981388A NO 981388 A NO981388 A NO 981388A NO 981388 L NO981388 L NO 981388L
Authority
NO
Norway
Prior art keywords
dupuytren
disease
improvement
Prior art date
Application number
NO981388A
Other languages
English (en)
Other versions
NO981388D0 (no
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of NO981388D0 publication Critical patent/NO981388D0/no
Publication of NO981388L publication Critical patent/NO981388L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
NO981388A 1997-03-27 1998-03-26 Bedring av Dupuytrens sykdom NO981388L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease

Publications (2)

Publication Number Publication Date
NO981388D0 NO981388D0 (no) 1998-03-26
NO981388L true NO981388L (no) 1998-09-28

Family

ID=25245473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981388A NO981388L (no) 1997-03-27 1998-03-26 Bedring av Dupuytrens sykdom

Country Status (8)

Country Link
US (2) US6086872A (no)
AU (1) AU733208B2 (no)
DE (1) DE19813748A1 (no)
DK (1) DK177324B1 (no)
FR (2) FR2772273B1 (no)
GB (1) GB2323530B (no)
NO (1) NO981388L (no)
SE (1) SE522723C2 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
JP4967081B2 (ja) * 2005-01-21 2012-07-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク 癒着性関節包炎の処置方法
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) * 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
CA2754461A1 (en) * 2009-03-06 2010-09-10 Halozyme, Inc. Temperature sensitive mutants of matrix metalloprotease 1 and uses thereof
US8702654B2 (en) 2009-03-25 2014-04-22 John M. Agee Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
ES2715204T3 (es) 2010-10-30 2019-06-03 Univ Oxford Innovation Ltd Tratamiento de la enfermedad de Dupuytren
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
PT2734216T (pt) 2011-07-20 2018-11-07 Mediwound Ltd Extrato proteolítico de bromelina para o tratamento de doenças do tecido conjuntivo
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
HUE046160T2 (hu) 2012-01-12 2020-02-28 Endo Global Ventures Clostridium histolyticum enzim
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
WO2014107745A1 (en) 2013-01-07 2014-07-10 Halozyme, Inc. Metal sensitive mutants of matrix metalloproteases and uses thereof
DK2968484T3 (da) 2013-03-15 2021-02-22 Biospecifics Tech Corporation Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
JP2020511284A (ja) 2017-03-01 2020-04-16 エンド ベンチャーズ リミテッド セルライトを評価及び処置するための装置及び方法
US11473074B2 (en) * 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
AU2020366008A1 (en) 2019-10-15 2022-06-02 Biospecifics Technologies Corp. Treatment of uterine fibroids using purified collagenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
SE522723C2 (sv) 2004-03-02
GB2323530A (en) 1998-09-30
FR11C0033I1 (no) 2011-09-23
NO981388D0 (no) 1998-03-26
US6086872A (en) 2000-07-11
DE19813748A1 (de) 1998-10-01
SE9800806L (sv) 1998-09-28
DK40398A (da) 1998-09-28
GB9805050D0 (en) 1998-05-06
GB2323530B (en) 2001-10-10
DK177324B1 (da) 2013-01-07
FR2772273B1 (fr) 2003-04-25
SE9800806D0 (sv) 1998-03-12
AU5966198A (en) 1998-10-01
FR2772273A1 (fr) 1999-06-18
AU733208B2 (en) 2001-05-10
FR11C0033I2 (fr) 2012-03-16
USRE39941E1 (en) 2007-12-18

Similar Documents

Publication Publication Date Title
NO981388L (no) Bedring av Dupuytrens sykdom
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
NO953262D0 (no) Bedring av Dupuytrens sykdom
NO20002686D0 (no) Forbedring av Peyronies sykdom
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
NO982473D0 (no) 5'-Deoksy-cytidinderivater
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
IT244003Y1 (it) Tenuta d'albero
UA1629S (uk) Набір фестонів "веснянка-5"
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга
UA1951S (uk) Етикетка медичного препарату "валідол"
UA2094S (uk) Етикетка медичного препарату "аспаркам"
UA1957S (uk) Етикетка медичного препарату "аспаркам"
GB9717142D0 (en) Diagnosis of alzheimer's disease
KR960031066U (ko) 자동차용 인사이드 밀러의 체결구조
UA1150S (uk) Гра кубики-абетка "піктограми-здоров'я"
UA2230S (uk) Етикетка медичного препарату "гідроперит"
UA1999S (uk) Етикетка медичного препарату "димексид"
MA26665A1 (fr) Combination d'anticorps
UA1487S (uk) Міні-пальто жіноче хутрове
UA1482S (uk) Міні-пальто жіноче хутрове
UA1488S (uk) Міні-пальто жіноче хутрове
UA2127S (uk) Міні-пальто жіноче хутрове
UA1529S (uk) Міні-пальто жіноче хутрове
UA2133S (uk) Міні-пальто жіноче хутрове

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application